新生儿输血治疗的管理：意大利新生儿输血循证建议简介  

The management of neonatal transfusion therapy： brief introduction of evidence - based recommendations of neonatal transfusion therapy in Italy

作　　者：李茂军[1] 吴青[1] 阳倩[1] 唐彬秩[1] 陈昌辉[1] 

机构地区：[1]四川省医学科学院、四川省人民医院儿科,成都610072

出　　处：《中华实用儿科临床杂志》2017年第14期1063-1066,共4页Chinese Journal of Applied Clinical Pediatrics

摘　　要：输血治疗是新生儿期常用的干预措施之一，红细胞输注仍为大多数新生儿贫血病例的唯一治疗手段，但应用指征和实施策略尚不完善，输血的益处、不良后果及潜在风险还有待评估。输血管理中还有很多不确定的问题。现简要介绍意大利输血医学和免疫血液学会和意大利新生儿学会工作组发布的新生儿输血建议，以供国内临床医师参考。Blood transfusion therapy is one of the commonly used intervention in newborn infants. Red blood cell transfusion is the only treatment for most cases of neonatal anemia, but the indications of application and implemen- tation strategy are not yet perfect, and the benefits, adverse outcomes and potential risk of transfusion remains to be evaluated. There are many uncertain problems in transfusion management. This paper mainly introduces the evidence - based recommendations of neonatal blood transfusion released by Italian Society of Transfusion Medicine and Immuno- haematology and Italian Society of Neonatology Working Group for reference of domestic clinicians.

关 键 词：婴儿 新生 输血 管理 

分 类 号：R722.1[医药卫生—儿科]